Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
CryptoHoldings Opens CHT Public Offer on Base, Launches DAO Voting for First Planned Property
-
Wreaths Across America Announces the Mobile Education Exhibit 2027 National Tour Schedule
-
Quantum X Labs Launches End-to-End Quantum Error Correction Program at the Israeli Quantum Computing Center Operated by Quantum Machines
-
Ponce Financial Group, Inc. Reports Third Quarter 2026 Results
-
A Personalized Cancer Therapy Delivered Positive Phase 3 Results; The Next Race Is Picking Better Targets
-
Medicenna Reports Potent CD122 Blockade and Extended Survival with MDNA209 in Preclinical Models of Autoimmune Disease
-
Important Notice Long-Term Shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD); Erasca, Inc. (NASDAQ: ERAS); Power Solutions International, Inc. (NASDAQ: PSIX); and The Simply Good Foods Compan
-
SKYX and Its Subsidiary Deako Announce They Expect to Supply 60,000 Units of Their Smart Home Technologies to over 700 Homes to Prominent Oklahoma & Texas Home Builder, Home Creations in The Next
-
Slide Insurance Expands into Texas and Rhode Island
-
SaverOne Unveils New Software-Only Driver Safety Product, Unlocking a Significantly Larger Global Market Opportunity
-
ParaZero Launches TillOnAIR, an Autonomous Detect-to-Defeat C-UAS System with Reusable Interceptors
-
AITX Defines Four Internal Breakeven Milestones
-
Steelworkers urge province to save, modernize eastern Ontario long-term care homes
-
SmartKargo Launches AI Apps Portfolio to Help Airlines Reduce Risk, Drive Revenue, and Cut Cost
-
Ambros Therapeutics Announces Planned Interim Analysis of Phase 3 Clinical Trial Following FDA Feedback
-
Sampo will host an Investor Update in London on 17 November 2026
-
Telos Corporation to Announce Third Quarter 2026 Financial Results on November 9, 2026
-
iMerit, an EXL Company, launches iMerit Scholars platform as AI talent war shifts to domain expertise
-
Daré Bioscience to Showcase Its Investigational Programmable Device, DARE-IDDS, at PODD 2026: One Device, Designed to Deliver 100+ Doses and to be Controlled Wirelessly
-
Business First Bancshares, Inc. Announces Financial Results for Q3 2026
-
Consolidated Water Sets Investor Conference Call to Discuss Third Quarter 2026 Results on Tuesday, November 10, 2026 at 11:00 a.m. ET
-
PSB Holdings, Inc. Reports Quarterly Earnings of $0.94 Per Share
-
Worldwide NFT, Inc. Announces Signing LOI to Acquire Federal Cybersecurity Provider
-
Citizens Community Bancorp, Inc. Reports Third Quarter 2026 Earnings of $0.56 Per Share; Board Approves 14% Increase in Quarterly Dividend to $0.12 per Share
-
Fuel Tech Announces Air Pollution Control Contracts Valued at Approximately $3.3 Million
-
Hallador Energy Company Schedules Third Quarter 2026 Conference Call for November 9, 2026 at 5:00 p.m. ET
-
Equillium Announces First Subject Dosed in Phase 1 Clinical Trial of EQ504
-
Star Equity Holdings Expands Energy Services Division with Machine Shop Acquisition in Vernal, Utah
-
Illinois Lottery Achieves Record Sales, Generates Funding for K-12 Education
-
Propanc Biopharma Publishes New Data: PRP Reprograms Chemotherapy-Resistant Pancreatic Cancer Cells & Restores Therapeutic Vulnerability
-
Savaria Announces Date for Third Quarter 2026 Financial Results
-
New Indigenous Graduates Ready for Careers in Clean Water
-
Critical Metals Corp. Acquisition of European Lithium Approved by Supreme Court of Western Australia
-
Nuvectis Reports Positive Data from NXP200 Phase 1b Study Demonstrating Durable Responses, Including Complete Responses, in BRAF V600-mutated Recurrent or Progressive Gliomas
-
GCM Grosvenor to Announce Third Quarter 2026 Financial Results and Host Investor Conference Call on November 9, 2026
-
Weight Watchers Schedules Third Quarter 2026 Earnings Conference Call
-
Acuity Announces Agreement to Acquire Parameter Technologies
-
Inspection, Automation Equipment Could Be Overlooked Winners of the AI Buildout
-
SS Innovations Showcases SSi Mantra Telesurgery Capabilities at October 2026 Conferences
-
CytoDyn Presents Updated Leronlimab Data in Metastatic Colorectal Cancer at ESMO Congress 2026
-
Roze AI Receives U.S. Patent Notice of Allowance for Shortest Evacuation Route Technology
-
Allogene Therapeutics Announces Participation in Upcoming Investor Conferences
-
Propanc Biopharma Publishes New Data: PRP Reprograms Chemotherapy-Resistant Pancreatic Cancer Cells & Restores Therapeutic Vulnerability
-
Correction: Transaction in Own Shares
-
Safe Harbor Financial Signs Non-Binding Term Sheet to Combine with Opifex Media, Creating a Nasdaq-Listed Diversified Holding Company
-
Strive Announces $1.0 Billion SATS At-The-Market Program
-
Nexentis: MitoCareX Bio Advances AI-Driven Drug Discovery Initiative with Boltz, Completing Initial Computational Screening Stage
-
Prepayments (CK93) - Totalkredit A/S
-
Prepayments (CK93) - Nykredit Realkredit A/S
-
Major shareholder announcement
